参考文献/References:
[1]Siegel RL,Miller KD,Jemal A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.[2]方文涛.通过食管癌TNM新分期(第八版)解读2017年NCCN食管鳞癌诊疗指南[J].中华胃肠外科杂志,2017,20(10):1122-1126.[3]Eyck BM,Onstenk BD,Noordman BJ,et al.Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis[J].Ann Surg,2020,271(2):245-256.[4]Li X,Zhou F,Jiang C,et al.Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis[J].PLoS One,2014,9(7):e103162.[5]Schwarzenbach H,Hoon DS,Pantel K.Cell-free nucleic acids as biomarkers in cancer patients[J].Nat Rev Cancer,2011,11(6):426-437.[6]Duffy MJ,Mcdermott EW,Crown J.Blood- based bio-markers in breast cancer:from proteins to circulating tu-mor cells to circulating tumor DNA[J].Tumor Biology,2018,40(5):1010428318776169.[7]Ye Q,Ling S,Zheng S,et al.Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA[J].Mol Cancer,2019,18(1):114.[8]Azad T,Chaudhuri A,Fang P,et al.Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer[J].Gastroenterology,2020,158(3):494-505.[9]Pinsky PF,Prorok PC,Kramer BS.Prostate cancer screening - a perspective on the current state of the evidence[J].N Engl J Med,2017,376(13):1285-1289.[10]李红.基于靶向外显子测序的转移性乳腺癌患者血浆ERBB通路乳腺癌相关基因检测及临床意义研究[D].广东:南方医科大学,2017.[11]Chae YK,Oh MS.Detection of minimal residual disease using ctDNA in lung cancer:current evidence and future directions[J].J Thorac Oncol,2019,14(1):16-24.[12]Liu X,Zhang M,Ying S,et al.Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma[J].Gastroenterology,2017,153(1):166-177.[13]Talukdar FR,Di Pietro M,Secrier M,et al.Molecular landscape of esophageal cancer:implications for early detection and personalized therapy[J].Ann N Y Acad Sci,2018,1434(1):342-359.[14]Tian X,Sun B,Chen C,et al.Circulating tumor DNA 5-hydroxymethylcytosine as a novel diagnostic biomarker for esophageal cancer[J].Cell Res,2018,28(5):597-600.[15]Chen X,Gole J,Gore A,et al.Non-invasive early detection of cancer four years before conventional diagnosis using a blood test[J].Nat Commun,2020,11(1):3475.[16]Abbosh C,Birkbak NJ,Wilson GA,et al.Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution[J].Nature,2017,545(7655):446-451.[17]Eisenberger CF,Knoefel WT,Peiper M,et al.Squamous cell carcinoma of the esophagus can be detected by microsat ellite analysis in tumor and serum[J].Clin Cancer Res,2003,9(11):4178-4183.[18]Hiraiwa K,Takeuchi H,Hasegawa H,et al.Clinical significance ofcirculating tumor cells inblood from patients with gastrointestinalcancers[J].Ann Surg Oncol,2008,15(11):3092-3100.[19]李军,王伟,乔媛媛,等.食管鳞癌外周血循环肿瘤细胞检测及临床意义[J].中华胸心血管外科杂志,2012,28(3):157-160.[20]Kong W,Yang H,He L,et al.Micro ＲNA -155 is regulated by thetransforming growth factor beta /Smad pathway and contributesto epithelialcell plasticity by targeting Ｒ hoA[J].Mol Cell Biol,2008,28(22):6773-6784.[21]Egyud M,Tejani M,Pennathur A,et al.Ddtection of circulating tumor DNA in plasma:a potential biomarker for esophageal adenocarcinoma[J].Ann Thorac Surg,2019,108(2):343-349.[22]Kim K,Shin DG,Park MK,et al.Criculating cell-free DNA as a promising biomarker in patients with gastric cancer:diagnostic validity and significant reduction of cfDNA after surgical resection[J].Ann Surg Treal Res,2014,86(3):136-142.[23]Petty RD,Dahle-Smith A,Stevenson DAJ,et al.Gefitinib and EGFR gene copy number aberrations in esophageal cancer[J].J Clin Oncol,2017,35(20):2279-2287.[24]Punnoos EA,Atwal S,Liu W,et al.Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer:association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib[J].Clin Cancer Res,2012,18(8):2391-2401.[25]Cancer Genome Atlas Research Network.Integrated genomic characterization of oesophagealcarcinoma[J].Nature,2017,541(7636):169-175.[26]Wang K,Johnson A,Ali SM,et al.Comprehensive genomic profiling of advanced esophageal squamous cell carcinomas and esophageal adenocarcinomas reveals similarities and differences[J].Oncologist,2015,20(10):1132-1139[27]Chen M,Zhao H.Next-generation sequencing in liquid biopsy:cancer screening and early detection[J].Hum Genomics,2019,13(1):34.[28]Luo H,Li H,Hu Z,et al.Noninvasive diagnosis and moni-toring of mutations by deep sequencing of circulating tu-mor DNA in esophageal squamous cell carcinoma[J].Biochem Biophys Res Commun,2016,471(4):596-602.[29]Tomochika S,Iizuka N,Watanabe Y,et al.Increased serum cell-free DNA levels in relation to inflammation are predictive of distant metastasis of esophageal squamous cell carcinoma[J].Exp Ther Med,2010,1(1):89-92.[30]Sasaki Y,Tamura M,Koyama R,et al.Genomic characterization of esophageal squamous cell carcinoma:Insights from next-generation sequencing[J].World J Gastroenterol,2016,22(7):2284-2293.
相似文献/References:
[1]汪 兵,杜 铭.食管癌微创手术与机器人手术的研究[J].医学信息,2018,31(06):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
WANG Bing,DU Ming.Study on Minimally Invasive Surgery and Robotic Surgery for Esophageal Carcinoma[J].Medical Information,2018,31(07):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
[2]许益芬.三维适型放疗与调强放疗在胸中段食管癌根治性放疗中的
剂量学比较[J].医学信息,2018,31(13):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]
XU Yi-fen.Dosimetric Comparison of Three-dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Radical Radiotherapy of Middle Thoracic Esophageal Carcinoma[J].Medical Information,2018,31(07):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]
[3]茹仙古丽·艾尔西丁,木拉提·哈米提,严传波,等.RF和C4.5决策树在食管癌图像分类中的研究[J].医学信息,2018,31(22):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
Roxangvl·Arxidin,Murat·Hamit,YAN Chuan-bo,et al.Research on RF and C4.5 Decision Tree in Image Classification of Esophageal Cancer[J].Medical Information,2018,31(07):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
[4]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,31(07):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[5]王 猛.循环肿瘤细胞在肺癌诊疗中的临床研究进展[J].医学信息,2019,32(15):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]
WANG Meng.Progress in Clinical Research of Circulating Tumor Cells in the Diagnosis and
Treatment of Lung Cancer[J].Medical Information,2019,32(07):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]
[6]张小艳,赵 红,郑穗生,等.食管癌患者放射性肺损伤预测因素分析及其与
COPD的相关性研究[J].医学信息,2019,32(14):68.[doi:10.3969/j.issn.1006-1959.2019.14.022]
ZHANG Xiao-yan,ZHAO Hong,ZHENG Sui-sheng,et al.Predictive Factors Analysis of Radiation-Induced Lung Injury in Patients with
Esophageal Cancer and Its Correlation with COPD[J].Medical Information,2019,32(07):68.[doi:10.3969/j.issn.1006-1959.2019.14.022]
[7]杨玥欣,汪 志,杨 欣,等.食管癌放疗的剂量学和临床疗效研究[J].医学信息,2020,33(04):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
YANG Yue-xin,WANG Zhi,YANG Xin,et al.Dosimetry and Clinical Efficacy of Radiotherapy for Esophageal Cancer[J].Medical Information,2020,33(07):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
[8]刘安东,刘崇华,王园园.参麦注射液联合放射治疗对中晚期食管癌老年患者的疗效[J].医学信息,2020,33(16):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
LIU An-dong,LIU Chong-hua,WANG Yuan-yuan.The Effect of Shenmai Injection Combined with Radiotherapy on Elderly Patients with Advanced Esophageal Cancer[J].Medical Information,2020,33(07):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
[9]赵素素,谭洁琼,党 娟.食管癌术后恢复期补液量与术后恢复的关系[J].医学信息,2021,34(04):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
ZHAO Su-su,TAN Jie-qiong,DANG Juan.The Relationship Between the Amount of Fluid Supplementation in the Recovery Period and Postoperative Recovery of Esophageal Cancer[J].Medical Information,2021,34(07):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
[10]吴伯勋,刘 浩,刘洪利.香砂六君子汤在微创食管癌切除术后肠功能恢复中的应用效果[J].医学信息,2021,34(06):169.[doi:10.3969/j.issn.1006-1959.2021.06.045]
WU Bo-xun,LIU Hao,LIU Hong-li.Application Effect of Xiangsha Liujunzi Decoction in Recovery of Bowel Function After Minimally Invasive Esophageal Cancer Resection[J].Medical Information,2021,34(07):169.[doi:10.3969/j.issn.1006-1959.2021.06.045]